BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Nicola L, Di Lullo L, Paoletti E, Cupisti A, Bianchi S. Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice. J Nephrol 2018;31:653-64. [PMID: 29882199 DOI: 10.1007/s40620-018-0502-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiménez-Marrero S, Cainzos-Achirica M, Monterde D, Garcia-Eroles L, Enjuanes C, Yun S, Garay A, Moliner P, Alcoberro L, Corbella X, Comin-Colet J. Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis. Clin Epidemiol 2020;12:941-52. [PMID: 32982459 DOI: 10.2147/CLEP.S253745] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jiménez-marrero S, Cainzos-achirica M, Monterde D, Vela E, Cleries M, García-eroles L, Enjuanes C, Yun S, Garay A, Moliner P, Alcoberro L, Corbella X, Comin-colet J. Impacto clínico y en costes sanitarios de alteraciones de potasio en pacientes con enfermedades cardiovasculares, metabólicas y renales crónicas. Revista Española de Cardiología 2021;74:312-20. [DOI: 10.1016/j.recesp.2020.06.016] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Jiménez-Marrero S, Cainzos-Achirica M, Monterde D, Vela E, Cleries M, García-Eroles L, Enjuanes C, Yun S, Garay A, Moliner P, Alcoberro L, Corbella X, Comín-Colet J. Impact on clinical outcomes and health costs of deranged potassium levels in patients with chronic cardiovascular, metabolic, and renal conditions. Rev Esp Cardiol (Engl Ed) 2021;74:312-20. [PMID: 32694080 DOI: 10.1016/j.rec.2020.06.013] [Reference Citation Analysis]
4 Rossing P, Filippatos G, Agarwal R, Anker SD, Pitt B, Ruilope LM, Chan JCN, Kooy A, McCafferty K, Schernthaner G, Wanner C, Joseph A, Scheerer MF, Scott C, Bakris GL; FIDELIO-DKD Investigators. Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy. Kidney Int Rep 2022;7:36-45. [PMID: 35005312 DOI: 10.1016/j.ekir.2021.10.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 16.0] [Reference Citation Analysis]
5 Turban S, Juraschek SP, Miller ER 3rd, Anderson CAM, White K, Charleston J, Appel LJ. Randomized Trial on the Effects of Dietary Potassium on Blood Pressure and Serum Potassium Levels in Adults with Chronic Kidney Disease. Nutrients 2021;13:2678. [PMID: 34444838 DOI: 10.3390/nu13082678] [Reference Citation Analysis]
6 Kim GH. Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease. Electrolyte Blood Press 2019;17:1-6. [PMID: 31338108 DOI: 10.5049/EBP.2019.17.1.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Capelli I, Gasperoni L, Ruggeri M, Donati G, Baraldi O, Sorrenti G, Caletti MT, Aiello V, Cianciolo G, La Manna G. New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure. J Nephrol 2020;33:37-48. [PMID: 30989614 DOI: 10.1007/s40620-019-00600-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
8 Provenzano M, Minutolo R, Chiodini P, Bellizzi V, Nappi F, Russo D, Borrelli S, Garofalo C, Iodice C, De Stefano T, Conte G, Heerspink HJL, De Nicola L. Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care. J Clin Med 2018;7:E499. [PMID: 30513744 DOI: 10.3390/jcm7120499] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
9 Cook EE, Davis J, Israni R, Mu F, Betts KA, Anzalone D, Yin L, Szerlip H, Uwaifo GI, Fonseca V, Wu EQ. Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia. Adv Ther 2021;38:5238-52. [PMID: 34471991 DOI: 10.1007/s12325-021-01886-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mok Y, Ballew SH, Matsushita K. Chronic kidney disease measures for cardiovascular risk prediction. Atherosclerosis 2021;335:110-8. [PMID: 34556333 DOI: 10.1016/j.atherosclerosis.2021.09.007] [Reference Citation Analysis]
11 Bianchi S, Aucella F, De Nicola L, Genovesi S, Paoletti E, Regolisti G. Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol 2019;32:499-516. [PMID: 31119681 DOI: 10.1007/s40620-019-00617-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
12 Varallo FR, Trombotto V, Lucchetta RC, Mastroianni PC. Efficacy and safety of the pharmacotherapy used in the management of hyperkalemia: a systematic review. Pharm Pract (Granada) 2019;17:1361. [PMID: 31015873 DOI: 10.18549/PharmPract.2019.1.1361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Campbell P, McKeveney P, Donegan K, Ataliotis C, Patton C, Mullan R. Practical guidance for the use of potassium binders in the management of hyperkalaemia in patients with heart failure and/or chronic kidney disease. Br J Hosp Med (Lond) 2021;82:1-11. [PMID: 33914625 DOI: 10.12968/hmed.2021.0215] [Reference Citation Analysis]
14 Bussalino E, Panaro L, Marsano L, Bellino D, Ravera M, Paoletti E. Prevalence and clinical correlates of hyperkalemia in stable kidney transplant recipients. Intern Emerg Med 2021. [PMID: 33544373 DOI: 10.1007/s11739-021-02649-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Carrero JJ, González-Ortiz A, Avesani CM, Bakker SJL, Bellizzi V, Chauveau P, Clase CM, Cupisti A, Espinosa-Cuevas A, Molina P, Moreau K, Piccoli GB, Post A, Sezer S, Fouque D. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat Rev Nephrol 2020;16:525-42. [PMID: 32528189 DOI: 10.1038/s41581-020-0297-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
16 Provenzano M, De Francesco M, Iannazzo S, Garofalo C, Andreucci M, Genualdo R, Borrelli S, Minutolo R, Conte G, De Nicola L. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy. Int J Clin Pract 2020;74:e13475. [PMID: 31909866 DOI: 10.1111/ijcp.13475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lizaraso-Soto F, Gutiérrez-Abejón E, Bustamante-Munguira J, Martín-García D, Chimeno MM, Nava-Rebollo Á, Maurtua-Briseño-Meiggs Á, Fernández-Zoppino D, Bustamante-Munguira E, de Paz FJ, Grande-Villoria J, Ochoa-Sangrador C, Pascual M, Álvarez FJ, Herrera-Gómez F. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials. Front Med (Lausanne) 2021;8:686729. [PMID: 34490289 DOI: 10.3389/fmed.2021.686729] [Reference Citation Analysis]
18 Morales E, Cravedi P, Manrique J. Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options. Front Med (Lausanne) 2021;8:653634. [PMID: 34150795 DOI: 10.3389/fmed.2021.653634] [Reference Citation Analysis]
19 Borrelli S, De Nicola L, Minutolo R, Conte G, Chiodini P, Cupisti A, Santoro D, Calabrese V, Giannese D, Garofalo C, Provenzano M, Bellizzi V, Apicella L, Piccoli GB, Torreggiani M, Di Iorio BR. Current Management of Hyperkalemia in Non-Dialysis CKD: Longitudinal Study of Patients Receiving Stable Nephrology Care. Nutrients 2021;13:942. [PMID: 33804015 DOI: 10.3390/nu13030942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Shah LN, Matheson MB, Furth SL, Schwartz GJ, Warady BA, Wong CJ. Low variability of plant protein intake in the CKiD cohort does not demonstrate changes in estimated GFR nor electrolyte balance. Pediatr Nephrol 2021. [PMID: 34796391 DOI: 10.1007/s00467-021-05334-y] [Reference Citation Analysis]